385 related articles for article (PubMed ID: 26834952)
1. Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic).
Ishii K; Barrett AJ
Ther Adv Hematol; 2016 Feb; 7(1):17-39. PubMed ID: 26834952
[TBL] [Abstract][Full Text] [Related]
2. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
Sinkovics JG
Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
[TBL] [Abstract][Full Text] [Related]
3. Advances in immunotherapy for pediatric acute myeloid leukemia.
Bonifant CL; Velasquez MP; Gottschalk S
Expert Opin Biol Ther; 2018 Jan; 18(1):51-63. PubMed ID: 28945115
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in acute myeloid leukemia.
Arpinati M; Curti A
Immunotherapy; 2014; 6(1):95-106. PubMed ID: 24341888
[TBL] [Abstract][Full Text] [Related]
5. Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.
Shimoni A; Nagler A
Cancer Treat Res; 2002; 110():113-36. PubMed ID: 11908195
[TBL] [Abstract][Full Text] [Related]
6. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
7. The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia.
Algeri M; Merli P; Locatelli F; Pagliara D
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501237
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia effect on infant lymphoblastic leukemia relapsed after sibling hematopoietic stem cell transplantation.
Boatsman EE; Fu CH; Song SX; Moore TB
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e57-60. PubMed ID: 20168246
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in acute myeloid leukemia.
Grosso DA; Hess RC; Weiss MA
Cancer; 2015 Aug; 121(16):2689-704. PubMed ID: 26095886
[TBL] [Abstract][Full Text] [Related]
10. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
11. How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
Zhang M; Huang H
Front Immunol; 2020; 11():611710. PubMed ID: 33384696
[TBL] [Abstract][Full Text] [Related]
12. Redirecting the Immune Microenvironment in Acute Myeloid Leukemia.
Sendker S; Reinhardt D; Niktoreh N
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804676
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
Front Immunol; 2019; 10():295. PubMed ID: 30891031
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Acute Myeloid Leukemia: Allogeneic hematopoietic cell transplantation is here to stay.
Kaleka G; Schiller G
Leuk Res; 2022 Jan; 112():106732. PubMed ID: 34864447
[TBL] [Abstract][Full Text] [Related]
15. Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
Sobiak J; Kazimierczak U; Kowalczyk DW; Chrzanowska M; Styczyński J; Wysocki M; Szpecht D; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):385-95. PubMed ID: 26040247
[TBL] [Abstract][Full Text] [Related]
16. The Graft-Versus-Leukemia Effect in AML.
Sweeney C; Vyas P
Front Oncol; 2019; 9():1217. PubMed ID: 31803612
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.
Knorr DA; Goldberg AD; Stein EM; Tallman MS
Leuk Lymphoma; 2019 Dec; 60(14):3350-3362. PubMed ID: 31335250
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
[TBL] [Abstract][Full Text] [Related]
19. Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.
Perna F; Espinoza-Gutarra MR; Bombaci G; Farag SS; Schwartz JE
Cancer Treat Res; 2022; 183():225-254. PubMed ID: 35551662
[TBL] [Abstract][Full Text] [Related]
20. [Update on stem cell transplantation for acute leukemias].
Mineishi S
Rinsho Ketsueki; 2016; 57(10):2218-2223. PubMed ID: 27795533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]